The agency approved it based on two Phase III studies showing the drug to be as effective as another combination therapy at improving lung function.

The US Food and Drug Administration (FDA) has approved scPharmaceuticals’ supplemental new drug application (sNDA) for ...

Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success ...

Rouse had presented with symptoms including intense swelling in her legs that she originally thought could be linked to her ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ventyx Biosciences (VTYX – Research Report), ...